Summary: Psychedelic Support reports on the long-term follow-up results of six MAPS-sponsored Phase 2 clinical trials of MDMA-assisted psychotherapy for the treatment of PTSD. “Overall, after undergoing MDMA-assisted psychotherapy participants reported having better relationships, increased appreciation for life, and a greater sense of possibility and spirituality. The response was enduring for many at the long-term follow-up,” explains Psychedelic Support.
Originally appearing here.
